All blog posts
Total 13 results for
Showing 12 out of 13 results
12 March 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
18 August 2025
Pharma remains an enforcement focus in China – SAMR orders unwinding of a completed pharma deal
11 October 2024
The new UK Regulatory Innovation Office – a step in the right direction for UK life sciences
07 August 2024
A new Labour Government – what might this mean for the UK life sciences industry?
02 July 2024
Recent additions to Life Sciences Notes
28 June 2024
Overview of EU regulatory and competition law in the Pharma sector
11 October 2022
Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor
04 July 2022
Government formally establishes COVID-19 inquiry
04 May 2022
Court finds Government's Covid policy in care homes unlawful
05 April 2022
High Court considers judicial review of public sector appointments made during the pandemic
11 March 2022
Court of Appeal finds no breach of positive human rights duties
31 January 2022
Courts consider legality of procurement decisions taken during the pandemic
Showing 12 out of 13 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group